Search for Clinical Trial Results

Multiple Endocrine Neoplasia Type 1 - 9 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery Condition:
|
Not yet recruiting |
Study Name: Non-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO Treatment Condition: Pancreatic Neuroendocrine Tumors in MEN1 Date: 2016-03-02 Interventions: Drug: Somatostatin-Analog A long-acting somatostatin-analog will be applied. |
Recruiting |
Study Name: Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients Condition: Multiple Endocrine Neoplasia Date: 2017-02-07 |
Recruiting |
Study Name: Genetic Evaluation of Families With Endocrine Cancers Condition:
Date: 2013-02-15 Interventions: Genetic: Blood draw Blood draw |
Completed |
Study Name: Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer Condition:
|
Not yet recruiting |
Study Name: Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor Condition:
|
Recruiting |
Study Name: Familial Investigations of Childhood Cancer Predisposition Condition:
|
Recruiting |
Study Name: Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors) Condition:
Date: 2017-02-02 Interventions:
|
Completed |
Study Name: Capecitabine and Temozolomide for Neuroendocrine Cancers Condition: Neuroendocrine Tumors Date: 2009-03-23 Interventions:
|